Market Place
Sourcing Support
ESTEVE and KOWA enter into an Exclusive License for rights to E-58425
04 May 2021 //
PRNEWSWIRE
ESTEVE and KOWA enter into an Exclusive License for rights to E-58425
03 May 2021 //
PRNEWSWIRE
Kowa Achieves Goal Of Randomizing 10,000 Patients "PROMINENT" Of K-877
19 Feb 2020 //
PR NEWSWIRE
Patent For Cholesterol Drug Livalo Is Valid, Judge Rules
21 Sep 2017 //
LAW361
Livalo® (Pitavastatin Calcium): Kowa Company, Ltd. Et Al v.Hetero Drugs Limited
14 Jun 2017 //
PATENT LITIGATION
Cadila Healthcare settles patent litigation for Livalo tablets
17 Jan 2017 //
PHARMABIZ
New Data Demonstrate Pitavastatin More Effective Than Pravastatin
21 Jun 2016 //
PR NEWSWIRE
Chugai, Kowa expand license pact for SGLT2 inhibitor Deberza in US & EU
09 Nov 2015 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.